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Genetic and genomic health information increasingly informs routine clinical care and 
treatment. This systematic review aimed to identify the barriers and facilitators for nurses’ 




A search of Medline, EMBASE, CINAHL and PsycINFO generated 7823 articles, of which 48 
were included. Using narrative synthesis, barriers and facilitators were mapped to the 
Theoretical Domains Framework (TDF). 
 
Results 
Barriers were limitations to genetics knowledge and skill, low confidence initiating genetics 
discussions, lack of resources and guidelines, and concerns about discrimination and 
psychological harm. Facilitators were positive attitudes towards genetics, willingness to 




Nurses and physicians are largely underprepared to integrate genetic and genomic health 
information into routine clinical care. Ethical, legal and psychological concerns surrounding 
genetic information can lead to avoidance of genetics discussions. The knowledge-practice 





capacity of the current and next generation of nurses and physicians to integrate genetics 
and genomics into usual clinical practice is essential if opportunities afforded by precision 
medicine are to be fully realized. 
 

























During the past two decades, the field of human genetics has undergone significant change. 
The sequencing of the human genome has fueled understanding of the relationship 
between genetic variation and human health (1). Demand is such that clinical nurses and 
physicians working in a variety of clinical disciplines are now required to integrate genetics 
into routine care. For example, ovarian cancer patients with a DNA-repair deficiency may be 
exquisitely responsive to poly-ADP ribose polymerase inhibitors (2) and cardiologists may 
consider implantable cardioverter defibrillators for those at risk of sudden cardiac death (3). 
Reductions in the cost of genetic testing (4) and greater public access to and awareness of 
genetic information (5) means more people seek genetic information than ever before. 
Collectively, these changes have prompted the acceleration of genetic information as a 
critical element of care for many patient populations.  
 
Considering the changing landscape of genetic and genomic (herein referred to as ‘genetic’ 
only) opportunities, care pathways for patients to access genetic information need to adapt. 
Traditionally, access involved referral of patients to tertiary centers for genetic counseling. 
However, the demands on genetics services are outweighing workforce capacity (6), with 
policy makers calling for alternative genetic models of care (7, 8). One such model is 
‘mainstreaming’, which involves non-genetics nurses and physicians identifying at-risk 
individuals and initiating genetics discussions (9) by integrating genetics into practice. 
Examples include taking a family history, assessing the chance of a genetic condition, 
organizing genetic testing or delivering a genetic test result to a patient. The benefits of 
identifying individuals with a genetic condition through mainstreaming are three-fold: 





to other possible health problems the individual could face; and the individual’s relatives 
can be offered predictive testing (targeted testing for the genetic condition identified in 
their relative). Predictive testing guides the relative’s need for health screening or risk 
management. 
 
Despite the benefits of genetic health information, translation of research to clinical practice 
is slow, highlighting the complex and interconnected barriers and facilitators within 
healthcare pathways (10). Identifying the underlying barriers and facilitators to nurses and 
physicians integrating genetics into their practice will lay the groundwork for the 
development of an evidence-based intervention to encourage behavior change (11). The 
aim of this review was to identify the barriers and facilitators for nurses and physicians 
working in secondary and tertiary care to integrate genetics and genomics into their usual 
practice. The secondary aim was to explore the similarities and differences between the 
specialties and disciplines.  
 
MATERIALS AND METHODS 
This systematic review was registered with PROSPERO (CRD42019134752) and conducted in 
accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses 
(PRISMA) statement (12). MEDLINE, Cochrane Reviews Database of Systematic Reviews, 
PROSPERO and the Joanna Briggs Institute Systematic Reviews database were searched to 







The search strategy was developed in consultation with an information services librarian. 
MEDLINE, EMBASE, CINAHL and PsycINFO were searched on 30th August 2019 with no 
restrictions (MEDLINE search available in supplementary file 2). Further articles were 
elicited by backwards searching reference lists of included articles and relevant literature 
reviews, forwards searching articles using the Web of Science database, and reviewing first 
author profiles of included articles on ResearchGate (www.researchgate.net).  
 
Inclusion and exclusion criteria  
Inclusion and exclusion criteria were developed using the PICOS framework (12). Articles 
were included if they were reported after the first initial human genome sequence was 
published in February 2001 (1), published in English in a peer-reviewed journal, and 
reported empirical data on the barriers or facilitators nurses and/or physician encountered 
when providing genetic information to adults cared for in a secondary or tertiary healthcare 
setting. The Royal Australasian College of Physicians Advanced Training Programs were used 
as a specialty guide to include nurses and doctors who were most likely to work in 
secondary and tertiary care (13). Articles were excluded if they reported on direct-to-
consumer genetic testing, pharmacogenetic testing or reproductive carrier testing, or the 
nurse or physician worked in a primary care, pediatric, prenatal, research or clinical genetics 
setting. Primary care nurses and doctors were excluded due to the breadth of articles in this 
area and the existence of previous systematic reviews evaluating genetic interventions in 
the primary care setting (14). See supplementary file 3 for further details.  
 





Following de-duplication, one reviewer (SW) screened all articles against the inclusion and 
exclusion criteria by title and abstract and then by full text (see Figure 1). A 20% sample was 
allocated to a second reviewer (CJ) at both stages and interrater concordance was 
calculated using a prevalence-adjusted, bias-adjusted kappa statistic [≥0.7 (15)]. 
Disagreements were resolved through discussion. Up to three attempts were made to email 
authors of articles with missing or ambiguous information. 
 
Data items were predetermined using the Joanna Briggs data extraction instrument (16). 
Extraction was performed using QSR International's NVivo Version 12 and exported to an 
Excel spreadsheet. 
 
Risk of bias 
Individual risk of bias assessments were conducted using the QualSyst tool (17). With the 
aim of including a range of clinical disciplines, articles with a high risk of bias were not 
excluded. To assess for outcome reporting bias, published study protocols were searched 
using the World Health Organization’s (WHO) International Clinical Trial’s registry platform. 
No study protocols were identified in the initial systematic search, therefore publication bias 
could not be assessed. 
 
Data synthesis 
Narrative synthesis was performed using the Theoretical Domains Framework (TDF) to map 
the barriers and facilitators to higher behavioral domains and components (18). The TDF is a 
validated, comprehensive framework describing factors affecting health professional 






Extracted data items were grouped into themes. If the data item did not adequately 
correspond to an existing theme, a new theme was created. Each theme was mapped to a 
TDF domain and the frequency of each domain was calculated as a percentage of the total 
number of articles. The TDF domains sit within the Behaviour Change Wheel’s Capability-
Opportunity-Motivation Behaviour System (COM-B; (19)) and these components were used 
to organize and describe the results. This process is represented in Figure 2. The differences 




Nearly all of the 48 included articles were from high income countries (n=45, 94%). Half of 
the articles originated from the United States of America (USA) (n=25, 52%) and involved 
oncology nurses or physicians (n=24, 48%). The majority of articles were surveys (n=38, 
79%), which largely used novel, unvalidated instruments (37/38, 97%). Three-quarters of the 
articles only included physicians (n=35, 73%), were published after 2011 (n=36, 75%), and 
were assessed as having a low risk of bias (0.67 – 1.0; N=35, 73%). There were no significant 
differences in reported barriers and facilitators between quantitative, qualitative and mixed-
methods articles.  
 
Factors influencing integration of genetic counseling 
Most articles (n=40, 83%) reported both barriers and facilitators, while a small number only 
reported the facilitators (n=5, 10%) (20-24) or the barriers (n=3, 6%) (25-27). Themes were 





81%) and motivation (n=38 articles, 79%) to integrate genetics into practice (supplementary 
file 4).  
 
Capability to integrate genetics into practice 
Knowledge and Skill: 27 articles (56%) explored nurses’ and physicians’ knowledge of 
genetics (9, 26, 28-52), while 41 articles (85%) reported on their skills (9, 21-25, 27-35, 37-
47, 49-63). While nurses and physicians routinely engaged in discussions about genetics 
with their patients (22, 24, 29, 31, 38, 42, 47, 49, 52-56), all demonstrated limited 
understanding of general genetic concepts, and/or concepts relevant to their specialty (26, 
28-37). Despite knowledge deficits, nurses and physicians did engage in discussions about 
genetics with their patients (22, 24, 29, 31, 38, 42, 47, 49, 52-56). In some specialties, family 
history information was routinely obtained (21, 29, 30, 32, 33, 38, 39, 47, 49, 52-55), 
although the extent of the family history was not always adequate (28, 31, 32, 35, 39, 57). A 
smaller number of articles reported that physicians did assess genetic risk (23, 30, 34, 49, 
50, 52, 60, 61), however, confidence in family history and individual risk assessment was low 
(9, 29, 32, 35, 37, 38, 40, 43-45, 49, 53, 57-59). Four articles reported an inverse relationship 
between years of clinical practice and level of knowledge (29, 32, 33, 38). 
 
Oncologists and neurologists were most likely to order genetic testing. There were no 
reports of nurses or physicians from other specialties ordering testing [25, 26, 39, 49, 53, 59, 
60, 64-66]. Most nurses and physicians had low awareness of genetic tests relevant to their 
area of practice (28, 30, 38-43). They also had difficulty interpreting a genetic test result (28, 






Opportunity to integrate genetics into practice 
Environmental context & resources: 39 articles (81%) explored the impact of environmental 
context and resources on nurses’ and physicians’ ability to integrate into practice. Nurses 
and physicians infrequently referred patients to clinical genetics services (28, 29, 31-34, 36, 
38, 40, 51, 53-55, 60), primarily because of the prohibitive cost of accessing genetic testing 
(34, 39, 44-46, 60-65), lack of resources (32, 34, 37, 38, 44, 53, 61, 62, 65), absence of 
guidelines (26-28, 45, 55, 56, 61), and of lack of time to initiate a genetics discussions (36, 
37, 44, 53, 58, 59, 65). Some nurses and physicians had concerns about the privacy of 
genetic information or the process of informed consent (9, 37, 43, 44, 52, 64, 66). However, 
if patients raised questions or concerns about genetics, nurses and physicians did engage in 
these discussions (9, 24, 34, 36, 42, 43, 45, 49, 55, 60, 62).  
 
A small number of articles reported nurses and physicians actively avoided or refused to 
discuss genetics with their patients, where they felt genetics was not relevant to clinical care 
and there may be potential negative consequences of genetic information (21, 28, 36, 39, 
44). For example, some palliative care clinicians considered their clinical setting as 
inappropriate to initiate discussions about genetics and were disappointed when this had 
not been addressed previously (9, 40). Nurses and physicians reported the value of close 
working relationships or collaboration with clinical genetics professionals (9, 28, 29, 32, 34, 
37, 49, 56, 59, 62, 65). 
 






Belief about consequences: In total, 26 articles (54%) explored nurses’ and physicians’ belief 
about consequences. Nurses and physicians are cognizant of the potential medical benefit 
that genetic information can provide for patients (20, 34, 44, 45, 49, 55, 58, 59, 63, 65, 66), 
but this was tempered by concerns about the risk of psychological harm, such as inducing 
feelings of guilt or hopelessness (9, 25, 36, 37, 43, 44, 46, 49). The potential benefit to 
relatives was described, including clarifying family members’ risks and providing screening 
or family planning options (9, 28, 38, 44, 47, 52, 55). Some nurses and physicians worried 
about the emotional impact of genetic information on the family (9, 25, 36, 40, 46, 49). 
There were additional concerns about insurance and employment discrimination based on a 
genetic test result (29, 41, 43, 44, 46, 47, 64). 
 
Goals & Professional Role: Goals of the nurse or physician was explored by 11 articles (23%), 
while 14 articles (29%) reported views on professional roles. Nurses and physicians had 
mixed feelings about whether genetic information contributed to their clinical goals for the 
patient or aligned with their views about their professional role. Genetic information was 
not always perceived as particularly useful in the clinical setting (36, 39, 45, 58, 59, 61, 62, 
65). Genetic information was described as irrelevant by nurses and physicians in certain 
clinical disciplines, such as ophthalmology (36), and by particular professionals, such as 
breast surgeons (58, 59). Viewing genetics as irrelevant to clinical practice appeared to 
foster an active resistance to integrating genetics into practice (36, 58, 59). In contrast, 
nurses’ and physicians’ were confident in their competence to provide genetic information 
(9, 21, 38, 39, 41, 47, 49, 52, 53, 58, 59, 62) and in their view that genetic information 





However, nurses and physicians were uncomfortable about providing genetic health 
information to ‘at-risk’ relatives of their patients (31, 36, 49, 56, 58, 59).  
 
Intention & Optimism: Intention of the nurse or physician was explored by 16 articles (33%),  
while 14 articles (29%) reported on optimism. Nurses and physicians expressed positive 
attitudes towards genetics (9, 20, 24, 32, 34, 37, 55, 58, 59, 64, 66), reported their beliefs 
about the future benefit of genetic information for patients and society as a whole (22, 29, 
36, 47, 55, 64) and regarded genetic health information as an inevitable major factor in 
clinical care in the future (20, 37, 42, 58, 59). Nurses and physicians expressed their 
intention to engage in continuing professional education, demonstrating the need for 
increased genetic literacy. Most nurses and physicians preferred clinically relevant 
education in the form of workshops, lectures or online content (9, 21, 28-30, 33, 35, 36, 43, 
45, 47, 53, 56-59). Descriptions of nurses’ intentions to pursue further genetics education 
were more prevalent than articles reporting physicians’ intentions. 
 
DISCUSSION 
This systematic review identified that, while there are a number of indicators that nurses 
and physicians are engaging with and have positive attitudes towards genetics, there are 
also significant barriers that prevent them from doing this on a routine basis.  
 
Consistent with previous reports (67), this review identified that nurses and physicians 
under-refer patients who require, or may require, assessment of their genetic risk based on 
their diagnosis or family history. Although there are likely to be a number of additional 





knowledge. Nurses’ and physicians’ low confidence in engaging in discussions about 
genetics or performing genetics-related tasks (such as obtaining family history information, 
performing a risk assessment or interpreting a genetic test result) suggests an awareness of 
their limited knowledge. While it has been suggested that few nursing and medical 
undergraduate degrees adequately prepare graduates to integrate genetic health 
information into their clinical practice (68, 69), this review found that more recent nursing 
and physician graduates had better genetics knowledge scores than their more experienced 
colleagues (29, 32, 33, 38). Although an inverse relationship between years of practice and 
knowledge has been reported previously (70), this finding suggests educators are 
recognizing the importance of graduates having adequate genetics knowledge and 
incorporating this into undergraduate programs. It was noted, however, that articles 
describing nurses’ skill set were less prevalent than articles describing the abilities of 
physicians. For nurses and physicians who did not receive adequate genetics education in 
basic training or who trained a long time ago, accessing continuing professional 
development can be marred by financial and scheduling barriers (71).  
 
Collaborative relationships between the nurse or physician and clinical genetics 
professionals was highlighted in this review as a valuable resource, with the potential to 
improve access to genetics education and increase the number of appropriate referrals to 
clinical genetics services (72). Nonetheless, while some nurses and physicians do feel 
capable of raising and discussing relevant genetic health information with their patients, 
others appear to engage reactively to their patient’s request for genetic information or may 
feel obligated to initiate discussions where there are medical management implications 





appropriateness of genetics within their role were more prevalent than articles describing 
physicians’ views. Although issues of knowledge, skill, training and resources are playing a 
significant role, other important factors contribute to nurses and physicians capacity to 
integrate genetics information into their practice. 
 
Concerns about the ethical, legal and psychological aspects of genetic information appear to 
critically inform their motivation to integrate genetics into practice. Depending on the 
nurse’s or physician’s views, motivation to integrate genetics into practice may vary. 
Pleasingly, a substantial number reported the potential positive effect of genetic health 
information, such as personalizing and improving medical management or providing risk 
advice to relatives who can benefit from screening or risk-reducing interventions (2). 
However, only a small number of nurses and physicians feel genetic information can be 
improve psychological wellbeing (9, 37, 46). Concerns about the potential for genetic 
information to inflict psychological harm on patients were frequently reported, despite 
genetic counseling demonstrating an ability to reduce anxiety and improve accuracy of 
perceived genetic risk (74).  
 
Ethical and legal considerations, such as insurance or employment discrimination resulting 
from inappropriate sharing of genetic information, were also raised. While these concerns 
have been reported elsewhere by research participants and the general public, sharing of 
genomic data is widely considered to be a necessary step to improve understanding of the 
genetic basis of disease and future medical care (75). In this genomics era, government 
bodies are moving to develop ethical and legal safeguards for individuals and families, 





even after implementation (76). Meanwhile, nurses and physicians who have significant 
ethical, legal or psychological concerns about genetic information may actively avoid 
initiating conversations about genetics with their patients (36). Sidestepping the 
opportunity to explore a patient’s genetic concerns may mean a vital opportunity is missed, 
particularly in specialties like palliative care, which represent the final chance to collect 
valuable patient knowledge about family history or a DNA sample which could benefit their 
relatives (77).  
 
Implication for future research  
The majority of articles included in this review utilized an unvalidated survey to capture the 
barriers and facilitators faced by nurses and physicians in integrating genetics in their 
practice. Development of a validated tool to assess genetics practice, attitudes and 
knowledge could be considered in future research, to enable more accurate comparisons 
between different specialties and disciplines.  
 
To ensure patients and families have appropriate access to genetic health information, 
nurses and physicians need to successfully integrate genetics into their practice (11). To 
achieve this aim, there is a need for further research to understand the context-specific 
barriers and facilitators (for example in palliative care, oncology and neurology) and develop 
evidence-based, theory-informed interventions. 
 
Limitations 
Limitations of this review relate to both the individual articles and review methodology. As 





represent a range of disciplines and specialties, articles with high risk of bias were included, 
although their findings were present in other articles. Given resource issues, only English-
language articles were included. The review was strengthened by adhering to the PRISMA 
guidelines and the use of a theoretical framework to map and synthesize outcomes (10, 12). 
Although the findings of this review are not necessarily novel, synthesizing the literature to 




Building the capacity of nurses and physicians to integrate genetics and genomics into 
routine clinical care is essential if opportunities afforded by precision medicine are to be 
fully realized. Many nurses and physicians have limited knowledge and skills about genetics 
and genomics, do not feel confident addressing these issues with patients and lack 
resources and guidelines to direct them. Apprehension about ethical, legal and 
psychological impacts of genetic information influence willingness to engage in genetics 
discussions, unless requested by patients. This review identified potential behavioral targets 
to inform the development of theory-informed, evidence-based interventions to facilitate 
the integration of genetics into nurses’ and physicians’ usual care. Such interventions will 
need to be tailored to the specific clinical setting (11). 
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